Steven R. Goldstein, M.D., FACOG, CCD, NCMP is a Magna Cum Laude graduate of Colgate University with a Baccalaureate degree in Biology. He graduated from the New York University School of Medicine in 1975 and did an internship in Obstetrics and Gynecology at Parkland Memorial Hospital in Dallas, Texas in 1975-1976. He did a residency in Obstetrics and Gynecology at New York University Affiliated Hospitals/ Bellevue Hospital Center from 1976 to 1980. In 1980 he joined the Faculty of the Department of Obstetrics and Gynecology at New York University School of Medicine, rising to his current rank of Professor of Obstetrics and Gynecology, a tenured full time academic position. However, in this capacity he maintains a half time private practice as a generalist in Obstetrics and Gynecology in the Faculty Practice suites at New York University.
His longstanding interests in Ob/Gyn ultrasound have led him to his current position as Director of Gynecologic Ultrasound at New York University Medical Center. He is a Fellow of the American Institute of Ultrasound in Medicine and is currently President of this National organization. He is a Past President of the North American Menopause Society. He served on the Board of Directors of the American Registry of Diagnostic Medical Sonographers having prepared the test and administered policy for the certification of over 40,000 sonographers nationwide. He is a past Chairman of the American College of Obstetrics and Gynecology, New York Section. He was author of their Technical Bulletin “Ultrasound in Gynecology” as well as the author of their practice guidelines on SERMs (Selective Estrogen Receptor Moderators). He serves as the liaison physician from the American College of Obstetrics and Gynecology to the Women’s Health Imaging Panel of the American College of Radiology. He has been an examiner for the American Board of Obstetrics and Gynecology.
His pioneering work in menopausal and perimenopausal ultrasound led him into design of uterine safety studies for several Selective Estrogen Receptor Modulators. In addition he is the CoDirector of the Bone Densitometry Unit at NYU Langone Medical Center. Clinically his practice has evolved into issues of menopausal and perimenopausal medicine with particular interest in ultrasound applications both for adnexal masses and abnormal bleeding.
He has authored a textbook entitled “Endovaginal Ultrasound” and as well as one entitled “Ultrasound in Gynecology”. More recently, he authored “Imaging in the Infertile Couple” and one entitled “Textbook of Perimenopausal Gynecology”. He is one of the most highly recognized and regarded individuals in the field of vaginal probe ultrasound worldwide. He has authored more than 60 chapters in textbooks as well as over 80 original research articles. He has been a guest faculty member, invited speaker, visiting professor or course director over 400 times throughout the United States and in fact, the entire world.
Dr. Goldstein has a long history as an advisor and consultant to the pharmaceutical industry. He has been on gynecologic advisory boards and/or consulted for Amgen, Bayer, Boehringer Ingelheim, Eli Lilly, Merck, GlaxoSmithKline, Novo Nordisk, Wyeth, Proctor & Gamble, Warner Chilcott, Shionogi, QuatRx, Depomed, and Pfizer.
He has represented Eli Lilly, Pfizer and Mirabilis Medical and their appearances before FDA Advisory Boards. He has designed studies of uterine safety for Eli Lilly, Wyeth, Pfizer, and Glaxo Smith Kline. He holds two patents in the medical device arena. He has been a director of a publicly traded ultrasound company, Sonosite, Inc. from its inception until its sale to Fuji Medical in 2012.
He resides in New York City.